Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

INDIVIOR INC.

Filed by CROSSROADS STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-24 06:26:08 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
3607fcb0-065e-4073-b057-d9a3759cebaa
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Issues related to overdose reversal products including Naloxone; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2026 Commerce, Justice, Science, and Related Agencies Appropriations.

Literal federal measure citations: H.R.1968

MMM · Medicare/Medicaid

Medicaid policies related to substance use disorder; H.R.1, One Big Beautiful Bill Act.

Literal federal measure citations: H.R.1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.